Criscuolo, C.
Cianflone, A.
Lanzillo, R.
Carrella, D.
Carissimo, A.
Napolitano, F.
de Cegli, R.
de Candia, P.
La Rocca, C.
Petrozziello, T.
Matarese, G. http://orcid.org/0000-0001-9429-0616
Boscia, F.
Secondo, A.
Di Bernardo, D. http://orcid.org/0000-0002-1911-7407
Brescia Morra, V.
Funding for this research was provided by:
FISM Fondazione Italiana Sclerosi Multipla 2015/R6
Article History
Received: 23 April 2018
Accepted: 27 November 2018
First Online: 12 March 2019
Competing Interests
: Dr. V.B.M. and R.L. received personal fees for public speaking or consultancy from Merck, Novartis, Biogen, Genzyme, Teva and Almirall. The remaining authors declare no competing interests.